Market Overview

The Global Circulating Tumor Cells (CTC) Market was valued at USD 11,733.9 million in 2023 and is expected to reach USD 31,952.6 million by 2031 while growing at a CAGR of 13.3% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global circulating tumor cells (CTC) market growth. Circulating Tumor Cells (CTCs) are cancer cells that break away from the primary tumor, entering the bloodstream and potentially forming metastases in distant organs. Their presence in the bloodstream is a crucial step in the metastatic spread of cancer.

Advancements in diagnostic technologies and increased funding for cancer research are expected to drive substantial growth in the Circulating Tumor Cells (CTC) market. However, obstacles such as the high costs of CTC detection technologies and regulatory approval may hinder market expansion.

Furthermore, the global circulating tumor cells (CTC) industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Technology Analysis

The Global Circulating Tumor Cells (CTC) Market is segmented among CTC Enrichment Methods, and CTC Detection Methods, based on Technology. In 2023, CTC Detection Methods accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Circulating Tumor Cells (CTC) Market is segmented among Clinical/ Liquid Biopsy, and Research, based on Application. In 2023, Research accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Circulating Tumor Cells (CTC) Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Advanced Cell Diagnostics Inc., Aviva Biosciences, Biocept Inc., Creatv Micro Tech Inc., LungLife AI Inc., Menarini Silicon Biosystems, Miltenyi Biotec, Precision for Medicine (Formerly ApoCell), Qiagen NV, and BioChain Institute Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Circulating Tumor Cells (CTC) Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Circulating Tumor Cells (CTC) Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Circulating Tumor Cells (CTC) Market Segmentation, By Technology

• Global Circulating Tumor Cells (CTC) Market Share Analysis, By Technology

• Global Circulating Tumor Cells (CTC) Market Growth Analysis, By Technology

• Global Circulating Tumor Cells (CTC) Market Trends, By Technology

o CTC Enrichment Methods

Ø Positive Enrichment

Ø Negative Enrichment

Ø Other Technologies

o CTC Detection Methods

Ø Immunocytochemical Technology

Ø Molecular (RNA)-based Technology

Ø Other CTC Detection Methods

6. Global Circulating Tumor Cells (CTC) Market Segmentation, By Application

• Global Circulating Tumor Cells (CTC) Market Share Analysis, By Application

• Global Circulating Tumor Cells (CTC) Market Growth Analysis, By Application

• Global Circulating Tumor Cells (CTC) Market Trends, By Application

o Clinical/ Liquid Biopsy

o Research

7. Global Circulating Tumor Cells (CTC) Market Segmentation, By Region

• Global Circulating Tumor Cells (CTC) Market Share Analysis, By Region

• Global Circulating Tumor Cells (CTC) Market Growth Analysis, By Region

• Global Circulating Tumor Cells (CTC) Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Advanced Cell Diagnostics Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Aviva Biosciences

• Biocept Inc.

• Creatv Micro Tech Inc.

• LungLife AI Inc.

• Menarini Silicon Biosystems

• Miltenyi Biotec

• Precision for Medicine (Formerly ApoCell)

• Qiagen NV

• BioChain Institute Inc

 *Similar analysis will be provided for each company listed above.